Administrative Core
行政核心
基本信息
- 批准号:9762853
- 负责人:
- 金额:$ 13.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY (ADMINISTRATIVE CORE)
The Administrative Core provides essential support to the MD Anderson Cancer Center and Temple/Fox
Chase Cancer Center Leukemia SPORE PIs and investigators to maximize success. It is co-directed by Drs.
Hagop Kantarjian and Jean-Pierre Issa, who co-chair the Executive Committee and provide overall supervision
of five Projects, two additional Cores, Developmental Research (DRP) and Career Enhancement (CEP)
Programs, and scientific direction of the SPORE. The Core co-Directors rely on the extensive broad-based
scientific, research, and SPORE experience of the Internal and External Advisory Boards in critical decision-
making. Success of the complex interdisciplinary research in the SPORE depends on integration of diverse
leukemia research approaches. The Core will overcome barriers to interdisciplinary collaboration and data
sharing and will ensure a unified translational research effort. The SPORE is founded on planning, integration,
and translational research efforts supported by this Core. Its leadership and staff will be responsible for
monitoring/planning scientific activities; providing scientific direction; ensuring emphasis on translational
research; ensuring interdisciplinary and inter-SPORE integration with major leukemia programs within/outside
MD Anderson and other broad translational research activities; and providing optimal administrative and fiscal
management. Specific responsibilities of the Administrative Core are: Oversee and monitor all SPORE
activities; promote integration and communication among the SPORE-related clinical programs; monitor the
scientific integrity of all research projects, and grant awards; assure compliance with institutional,
governmental, and National Cancer Institute regulations; oversee the fiscal and budgetary activities of the
SPORE; coordinate data control quality assurance issues in conjunction with the Internal Advisory Board and
the Biostatistics, Data Management, and Bioinformatics Core (Core 3); coordinate activities associated with
clinical trials, including design of protocols, approval by regulatory bodies, implementation, and eligibility
screening and assignment of patients to different studies; provide oversight and support for Core 3 and the
Pathology and Tissue Core (Core 2); coordinate and manage meetings of the SPORE Executive Committee,
the Internal and External Advisory Boards, monthly investigator meetings, quarterly research meetings,
lectures, and symposia; administer the DRP and the CEP; coordinate interdisciplinary and inter-SPORE
interactions and exchanges/meetings with other Leukemia SPORE programs and investigators, and other
organ-site SPORE programs; administer the activities of the Patient Advocates; comply with, and improve
policies addressing recruitment and retention of women and minorities; organize seminars to bring to MD
Anderson consultants and speakers with expertise in various clinical and laboratory aspects of leukemia
research; maintain a Leukemia SPORE website focused on issues in leukemia translational research.
项目摘要(行政核心)
行政核心为MD Anderson癌症中心和Temple/Fox提供了必不可少的支持
追逐癌症中心白血病孢子和研究人员,以最大程度地提高成功。它由Drs共同指导。
Hagop Kantarjian和Jean-Pierre Issa,共同主席执行委员会,并提供整体监督
在五个项目中,有两个核心,发展研究(DRP)和职业增强(CEP)
程序和孢子的科学方向。核心联合导演依赖于广泛的广泛基础
内部和外部咨询委员会的科学,研究和孢子经验
制作。复杂的跨学科研究在孢子中的成功取决于多样化的整合
白血病研究方法。核心将克服跨学科协作和数据的障碍
分享并确保统一的翻译研究工作。孢子建立在计划,整合,
以及该核心支持的翻译研究工作。它的领导和员工将负责
监视/计划科学活动;提供科学方向;确保强调翻译
研究;确保与外部/外部主要白血病计划的跨学科和跨学科整合
MD Anderson和其他广泛的翻译研究活动;并提供最佳的行政和财政
管理。管理核心的特定责任是:监督和监视所有孢子
活动;促进与孢子有关的临床计划之间的整合和沟通;监视
所有研究项目的科学完整性和授予奖励;确保遵守机构,
政府和国家癌症研究所法规;监督
孢子;协调数据控制质量保证问题与内部顾问委员会结合
生物统计学,数据管理和生物信息学核心(核心3);协调活动
临床试验,包括协议的设计,监管机构的批准,实施和资格
将患者筛查和分配给不同的研究;提供对核心3的监督和支持
病理和组织核心(核心2);协调和管理孢子执行委员会会议,
内部和外部咨询委员会,每月调查员会议,季度研究会议,
讲座和专题讨论会;管理DRP和CEP;协调跨学科和跨学科
与其他白血病孢子计划和调查人员以及其他的互动和交流/会议以及其他
器官孢子计划;管理患者拥护者的活动;遵守并改进
解决妇女和少数民族招募和保留的政策;组织研讨会将MD带到MD
Anderson顾问和演讲者在白血病的各种临床和实验室方面具有专业知识
研究;维护白血病孢子网站,该网站的重点是白血病转化研究中的问题。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
HAGOP KANTARJIAN的其他基金
Epigenetics and Epigenetic Therapy in AML
AML 的表观遗传学和表观遗传学治疗
- 批准号:84997448499744
- 财政年份:2013
- 资助金额:$ 13.84万$ 13.84万
- 项目类别:
New Approaches to the Biology and Treatment of Myelodysplastic Syndromes (MDS)
骨髓增生异常综合征 (MDS) 的生物学和治疗新方法
- 批准号:74373457437345
- 财政年份:2005
- 资助金额:$ 13.84万$ 13.84万
- 项目类别:
New Approaches to the Biology and Treatment of Myelodysplastic Syndromes (MDS)
骨髓增生异常综合征 (MDS) 的生物学和治疗新方法
- 批准号:76280287628028
- 财政年份:2005
- 资助金额:$ 13.84万$ 13.84万
- 项目类别:
SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia
SPORE 德克萨斯大学 M.D. 安德森癌症中心 SPORE-白血病
- 批准号:84729268472926
- 财政年份:2003
- 资助金额:$ 13.84万$ 13.84万
- 项目类别:
SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia
SPORE 德克萨斯大学 M.D. 安德森癌症中心 SPORE-白血病
- 批准号:89184398918439
- 财政年份:2003
- 资助金额:$ 13.84万$ 13.84万
- 项目类别:
SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia
SPORE 德克萨斯大学 M.D. 安德森癌症中心 SPORE-白血病
- 批准号:91235479123547
- 财政年份:2003
- 资助金额:$ 13.84万$ 13.84万
- 项目类别:
SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia
SPORE 德克萨斯大学 M.D. 安德森癌症中心 SPORE-白血病
- 批准号:87343258734325
- 财政年份:2003
- 资助金额:$ 13.84万$ 13.84万
- 项目类别:
相似海外基金
Learning and Living with Wildfire Smoke: Creating Clean Air Environments in Schools through Youth Participatory Action Research
与野火烟雾一起学习和生活:通过青年参与行动研究在学校创造清洁的空气环境
- 批准号:1066267410662674
- 财政年份:2023
- 资助金额:$ 13.84万$ 13.84万
- 项目类别:
SPORE University of Texas M. D. Anderson Cancer Center-Leukemia
SPORE 德克萨斯大学 MD 安德森癌症中心 - 白血病
- 批准号:1091171310911713
- 财政年份:2023
- 资助金额:$ 13.84万$ 13.84万
- 项目类别:
SAR 2023: From Mechanism to Patient-Centered Care: Research in Acupuncture and Traditional East Asian Medicine
SAR 2023:从机制到以患者为中心的护理:针灸和传统东亚医学研究
- 批准号:1060912410609124
- 财政年份:2023
- 资助金额:$ 13.84万$ 13.84万
- 项目类别: